Biote Corp. (BTMD) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Biote Corp., updated every trading day.
Health Care · Medicinal Chemicals and Botanical Products
Price
$1.15
−2.54% today
Market cap
$42M
Overall quality
40/100
Kronos AI 30-day
+39.8%
8 of 8 simulated paths end higher
Biote Corp. (BTMD) is a Health Care company in Medicinal Chemicals and Botanical Products, worth $42M. It trades at $1.15, down 2.54% today, at 5.5 times earnings. Its overall quality score is 40 out of 100, ranked against the whole US market. 4 analysts' average target of $2.00 implies +73.9% from today's price. Kronos AI's 30-day forecast is +39.8% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $2.00 |
| Low – high | $1.50 – $2.50 |
| Analysts | 4 |
| Upside to average | +73.9% |
Kronos AI 30-day forecast
| Expected close | $1.65 (+39.8%) |
| Likely range | +26.4% … +59.2% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 41 |
| Solvency | 26 |
| Growth | 53 |
| Overall | 40 |
| P/E | 5.5 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Medicinal Chemicals and Botanical Products
For information only, not investment advice. Prices updated: 2026-10-29.